Deletion and duplication of 16p11.2 are associated with opposing effects on visual evoked potential amplitude

被引:26
|
作者
LeBlanc, Jocelyn J. [1 ,2 ,3 ]
Nelson, Charles A. [1 ,4 ]
机构
[1] Boston Childrens Hosp, Labs Cognit Neurosci, Div Dev Med, Boston, MA 02115 USA
[2] Boston Childrens Hosp, Dept Neurol, FM Kirby Neurobiol Ctr, Boston, MA USA
[3] Harvard Med Sch, Dept Neurobiol, Boston, MA USA
[4] Harvard Med Sch, Dept Pediat, Boston, MA 02215 USA
来源
MOLECULAR AUTISM | 2016年 / 7卷
关键词
16p11.2 copy number variation; Visual evoked potential; Visual cortex; SENSORY PROCESSING DEFICITS; SCHIZOPHRENIA; AUTISM; MATURATION; CHILDREN; INFANTS; LATENCY; ACUITY; LOCUS; STATE;
D O I
10.1186/s13229-016-0095-7
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background: Duplication and deletion of the chromosomal region 16p11.2 cause a broad range of impairments, including intellectual disability, language disorders, and sensory symptoms. However, it is unclear how changes in 16p11.2 dosage affect cortical circuitry during development. The aim of this study was to investigate whether the visual evoked potential (VEP) could be used as a noninvasive quantitative measure of cortical processing in children with 16p11.2 copy number variation. Methods: Pattern-reversal VEPs were successfully recorded in 19 deletion carriers, 9 duplication carriers, and 13 typically developing children between the ages of 3 and 14 years. The stimulus was a black and white checkerboard (60') that reversed contrast at 2 Hz. VEP responses were extracted from continuous EEG recorded using a high-density elasticized electrode net. Results: Quantitative analysis of the VEP waveform revealed that, relative to controls, deletion carriers displayed increased amplitude and duplication carriers displayed diminished amplitude. Latencies of the VEP waveform components were unaffected by 16p11.2 status. P1 amplitude did not correlate with age, IQ, or head circumference. Conclusions: The results of this study suggest that recording VEP is a useful method to assay cortical processing in children with 16p11.2 copy number variation. There is a gene dosage-dependent effect on P1 amplitude that merits further investigation. The VEP is directly translatable to animal models, offering a promising way to probe the neurobiological mechanisms underlying cortical dysfunction in this developmental disorder.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] 16p11.2 duplication syndrome-associated psychosis: An illustrative case and review of the literature
    Colijn, Mark Ainsley
    SCHIZOPHRENIA RESEARCH, 2025, 275 : 76 - 78
  • [42] Hyperinsulinaemic Hypoglycaemia: A New Presentation of 16p11.2 Duplication Syndrome
    Conwell, Louise
    Flanagan, Sarah
    HORMONE RESEARCH IN PAEDIATRICS, 2019, 91 : 159 - 159
  • [43] TRANSCRIPTOMIC SIGNATURE OF THE 16P11.2 DUPLICATION IN CULTURED NEURONS AND BRAIN
    Akula, Nirmala
    Jiang, Xueying
    Liu, Siyuan
    Kassem, Layla
    Detera-Wadleigh, Sevilla
    England, Bryce
    Raznahan, Armin
    McMahon, Francis J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S104 - S105
  • [44] Understanding copy number variations through their genes: a molecular view on 16p11.2 deletion and duplication syndromes
    Leone, Roberta
    Zuglian, Cecilia
    Brambilla, Riccardo
    Morella, Ilaria
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [45] Microdeletion of 16p11.2 Associated With Endocardial Fibroelastosis
    Puvabanditsin, Surasak
    Nagar, Michael S.
    Joshi, Meera
    Lambert, George
    Garrow, Eugene
    Brandsma, Erik
    AMERICAN JOURNAL OF MEDICAL GENETICS PART A, 2010, 152A (09) : 2383 - 2386
  • [46] Overexpression of CD47 is associated with brain overgrowth and 16p11.2 deletion syndrome
    Li, Jingling
    Brickler, Thomas
    Banuelos, Allison
    Marjon, Kristopher
    Shcherbina, Anna
    Banerjee, Sravani
    Bian, Jing
    Narayanan, Cyndhavi
    Weissman, Irving L.
    Chetty, Sundari
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (15)
  • [47] Hyperinsulinaemic hypoglycaemia: A new presentation of 16p11.2 deletion syndrome
    Kostopoulou, Eirini
    Dastamani, Antonia
    Caiulo, Silvana
    Antell, Hannah
    Flanagan, Sarah E.
    Shah, Pratik
    CLINICAL ENDOCRINOLOGY, 2019, 90 (05) : 766 - 769
  • [48] 16p11.2 Deletion Syndrome in Prenatal Diagnosis - a rare case
    Freitas, Manuela Mota
    Candeias, Cristina
    Pires, Silvia
    Oliva-Teles, Natalia
    Tavares, Purificacao
    Rodrigues, Maria Do Ceu
    Fonseca E Silva, Maria Da Luz
    MOLECULAR CYTOGENETICS, 2017, 10
  • [49] Brain Structure Changes in a 16p11.2 Deletion Mouse Model
    Nickl-Jockschat, Thomas
    Jangir, Vinod Kumar
    Grissom, Nicola
    McKee, Sarah
    Schoch, Hannah
    Bowman, Nicole
    Havekes, Robbert
    Kumar, Manoj
    Pickup, Stephen
    Poptani, Harish
    Reyes, Teresa
    Abel, Ted
    NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S288 - S288
  • [50] Language and Communication Deficits in Chromosome 16p11.2 Deletion Syndrome
    Salud Jimenez-Romero, Ma
    Fernandez-Urquiza, Maite
    Benitez-Burraco, Antonio
    JOURNAL OF SPEECH LANGUAGE AND HEARING RESEARCH, 2022, 65 (12): : 4724 - 4740